newsfilter
← Latest News
Business Wire·

Dicerna Announces Data to Be Presented at American Society of Nephrology (ASN) Kidney Week 2021

– Data From PHYOX™2 Pivotal Trial of Nedosiran for Treatment of Primary Hyperoxaluria (PH) Accepted as Late-Breaker Poster Presentation – – Company on Track to Submit Nedosiran New Drug Application (NDA) to the U.S. Food and Drug Administrati